Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Intraaortic balloon pump
DEVICE
2 trials
Sponsors
Deutsches Herzzentrum Muenchen
, University of Leipzig
Conditions
Myocardial Infarction
Shock, Cardiogenic
Phase 4
Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)
Completed
NCT00417378
Deutsches Herzzentrum Muenchen
Myocardial Infarction, Shock, Cardiogenic
Start: 2004-08-31
End: 2006-03-31
Updated: 2007-11-28
Intraaortic Balloon Pump in Cardiogenic Shock II
Completed
NCT00491036
University of Leipzig
Myocardial Infarction, Shock, Cardiogenic
Start: 2009-06-30
End: 2016-10-31
Updated: 2017-05-02
Related Papers
GLP-1 in patients with myocardial infarction complicated by cardiogenic shock-an IABP-SHOCK II-substudy.
2024-01-03
3 citations
The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction
European Heart Journal
2021-02-10
123 citations
Arterial Lactate in Cardiogenic Shock: Prognostic Value of Clearance Versus Single Values.
2020-10-01
99 citations
Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction
Circulation
2019-01-14
402 citations
Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction.
2017-04-01
294 citations
Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock
Heart
2017-02-07
21 citations
Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock.
2016-12-08
37 citations
Editor’s Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial
European Heart Journal Acute Cardiovascular Care
2016-09-21
36 citations
Angiopoietin-2 in Acute Myocardial Infarction Complicated by Cardiogenic Shock—a Biomarker Substudy of the IABP-SHOCK II-Trial
European Journal of Heart Failure
2015-09-03
54 citations
Impairment of the Endothelial Glycocalyx in Cardiogenic Shock and its Prognostic Relevance
Shock
2015-02-18
51 citations
Economic implications of intra-aortic balloon support for myocardial infarction with cardiogenic shock: an analysis from the IABP-SHOCK II-trial.
2015-01-31
12 citations
Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
2014-12-21
32 citations
Growth-Differentiation Factor 15 and Osteoprotegerin in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Biomarker Substudy of the IABP-SHOCK II-Trial
European Journal of Heart Failure
2014-06-05
62 citations
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.
2013-09-03
625 citations
Intraaortic balloon support for myocardial infarction with cardiogenic shock.
2012-08-26
1811 citations
A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
2008-11-01
728 citations